Advancements in understanding tumor biology, identifying predictive biomarkers, and developing targeted therapies have ...

Clinicians from Fox Chase Cancer Center at Temple University Health share their highlights from the Society of Urologic ...

Athira has acquired an exclusive global license (excluding Asia and certain countries in the Middle East) from Sermonix Pharmaceuticals, Inc. for rights to develop and commercialize lasofoxifene, a ...

In a person living with HIV, proviruses—strands of HIV DNA—are typically integrated into the T cell genome and become a ...

"I still to this day don't know how I turned up for work next day," a medical professional writes when asked about the worst ...

Researchers at Johns Hopkins Medicine have reported evidence that standard chemotherapeutic drugs may selectively suppress ...

Scott Adams explained that doctors are working on a plan to move him to a treatment facility for radiation to target a tumor ...

The current melanoma staging system does not always reflect actual survival outcomes. In some cases, patients with thick but ...

When surgeons remove an aggressive bone tumor from the pelvis, saving a patient's life can mean sacrificing a large portion ...

Adding romosozumab to ongoing denosumab treatment shows increased lumbar spine bone mineral density with preserved anabolic ...

PITTSBURGH, Dec. 18, 2025 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced four recent regulatory milestones spanning across all stages of its global pipeline: ...

A national prospective study has confirmed a long-suspected link between Agent Orange and a rare but serious form of blood ...